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Drug addiction can be a devastating and chronic relapsing disorder with social, psychological, and physical consequences, and
more effective treatment options are needed. Repetitive transcranialmagnetic stimulation (rTMS) is a noninvasive brain stimulation
technique that has been assessed in a growing number of studies for its therapeutic potential in treating addiction.This review paper
offers an overview on the current state of clinical research in treating drug addiction with rTMS. Because of the limited research in
this area, all studies (including case reports) that evaluated the therapeutic use of rTMS in nicotine, alcohol, or illicit drug addiction
were included in this review. Papers published prior to December 2012 were found through an NCBI PubMed search. A total of
eleven studies were identified that met review criteria. There is nascent evidence that rTMS could be effective in reducing cocaine
craving and nicotine and alcohol craving and consumption and might represent a potential therapeutic tool for treating addiction.
Further studies are needed to identify the optimal parameters of stimulation for the most effective treatment of drug addiction, to
improve our comprehension of the treatment neurophysiological effects, and to conduct rigorous, controlled efficacy studies with
adequate power.
1. Introduction
Psychoactive drugs act on the central nervous system and
recurring drug intoxication can result in addiction, a complex
disease process of the brain which can be treated [1]. Addic-
tion can be described as a persistent state in which there is
reduced capacity to control compulsive drug-seeking, regard-
less of whether it involves risk of negative consequences [2, 3].
It is often a devastating and chronically relapsing disorder
with social, psychological, and physical consequences. Drug
addiction incurs enormous medical, economic, and social
costs.The currently available treatment options for addiction
remain somewhat limited and long-term success rates are
modest [4].
Brain stimulation allows modulation of activity in spe-
cific brain regions. Recently, nonsurgical brain stimulation
techniques have been utilized in examining the effects of
drug administration on cortical activity in order to further
explore the effects of repeated drug use on cortical excitability.
Furthermore, several novel studies have begun to assess brain
stimulation as a potential treatment for reducing addictive
behaviours [5].
This review paper offers an overview on the current state
of research in treating addiction in humans with transcranial
magnetic stimulation (TMS), a noninvasive brain stimulation
technique that may have therapeutic potential in treating
addiction.
Due to the limited amount of research in this area, all
studies (including case reports) that were identified through
an NCBI PubMed search (http://www.ncbi.nlm.nih.gov/)
were included in the review if published prior to December
2012 and if reporting on the evaluation of the therapeutic use
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of rTMS in tobacco, alcohol, or illicit drug addiction. Search
terms included “repetitive transcranial magnetic stimula-
tion,” and “rTMS,” with adjoining terms “addiction,” “drug,”
“nicotine,” “tobacco,” “alcohol,” “cocaine,” “opioids,” “heroin,”
“cannabis,” “marijuana,” “MDMA,” and “ecstasy.” A total of 11
studies were identified and included in this review and were
classified according to the system reported by Brainin et al.
[6] for the European Federation of Neurological Societies.
In this system, individual studies are rated on a continuum
based on the level of evidence as follows: class I requires a
rigorously conducted randomized clinical trial (RCT); class
II requires a less rigorously conducted RCT or a prospective
matched-group cohort study; class III requires any other type
of controlled trial; and class IV requires uncontrolled studies,
case series, case reports, or expert opinion. Based on the
evidence, the approaches are then rated in three levels: level
A indicates the approach is effective, ineffective, or harmful if
there is at least one class I study or two class II studies; level
B indicates the approach is probably effective, ineffective, or
harmful if there is at least one convincing class II study or
overwhelming class III evidence; and level C indicates the
approach is possibly effective, ineffective, or harmful if there
are at least two convincing class III studies.
2. Transcranial Magnetic Stimulation
TMS is a nonsurgical brain stimulation technique that is
proving to be valuable for both its research and therapeutic
potential within psychiatry [7]. TMS is able to modulate
cortical excitability and it is used to facilitate functional
brain mapping of cortical regions [8]. It uses a magnetic
pulse of high intensity, focused in a limited area, which
is administered through a coil. The extremely fast passage
of electric current in the coil induces a transient, high-
intensity magnetic pulse that penetrates through the scalp
and reaches the underlying cortex. In the targeted cortical
area, the magnetic pulse generates an electric current that
induces depolarization of superficial cortical neurons [9]. In
the region beneath the coil and interconnected areas a stim-
ulation occurs or a disruption of local neural activity [10, 11].
Repetitive TMS (rTMS) is used to induce longer lasting
alterations, facilitation, or functional disruptions. In rTMS,
trains of several pulses are delivered using various stimulation
patterns [12]. It provides a repeated stimulation of the scalp
at the same point with a frequency ranging from 1 to 20Hz
or more. The parameters in rTMS include its intensity, fre-
quency, length of trains of pulses, and time interval between
trains. The effects of rTMS are longer than TMS single pulse.
These long-term changes in the functioning of the cortex
produce effects that vary depending on the frequency of
stimulation, resulting in inhibition or facilitation.
While the long-lasting neurophysiologic effects of rTMS
are poorly understood, several studies showed that rTMS can
induce significant and long-lasting behavioural alterations,
including reduction in craving and consumption of drugs of
abuse.
The safety of TMS has been reported in a number of
studies [13–15] and the most recent guidelines for its use
have been published in 2009 by Rossi and colleagues [16].
The use of TMS is generally not recommended with patients
who have a history of epilepsy, in carrying a pacemaker,
with hearing aids, and with metal in any part of the body
and in pregnant women. Single pulses or low frequency
stimulation appears to carry little risk beyond occasionally
causing local discomfort at the site of stimulation. In some
circumstances, especially when the intensity of the magnetic
pulse is high, the effect of current induced by the magnetic
field can spread to the surrounding muscles on the head and
neck, causing contractions. Occasionally, mild or moderate
transient headache has been reported. Long-term effects of
repeated rTMS sessions are as yet unknown. Based on exist-
ing data, rTMS appears safe when administered according to
recommended guidelines, and its safety record supports its
further development as a clinical treatment [15, 17].
3. TMS and Cortical Excitability in Addiction:
Physiopathological Mechanisms
There were some reports of using TMS to measure cortical
inhibition in the cerebral cortex of subjects with substance
dependence [18–28]. These studies found that chronic expo-
sure to various addictive drugs induces alterations in cortical
excitability in the motor, occipital, and prefrontal cortex
(PFC). Cortical conductivity has been evaluated in individ-
uals with exposure to alcohol [18–22], with nicotine depen-
dence [23], with chronic cannabis exposure [24], with chronic
ecstasy exposure [25], and with cocaine addiction [26–28].
Decreased excitability in the motor cortex was found in
individuals who are cocaine [26–28] and nicotine dependent
[23]. Chronic cannabis use is associated with a reduction in
cortical inhibition [24]. Increased excitability of the visual
cortex was found in individuals with chronic MDMA use,
abstinent for 3 days [25]. Acute alcohol exposure was found
to be associated with decreased excitability in the motor
cortex [18, 19] and the PFC [20]. Moreover, Conte et al. [21]
proposed that while acute ethanol administration seemed
to affect GABA neurotransmission, chronic administration
appeared to alter the glutamate mechanisms involved in
cortical excitability.Nardone and colleagues (2010) found that
TMS showed a selective increase in intracortical facilitation
after ethanol withdrawal which supported the theory that
altered glutamatergic receptor function plays an important
role in the pathogenesis of human alcohol withdrawal [22].
Impaired cortical inhibition has been reported in persons
exposed to substances of abuse, suggesting that abnormal
cortical excitability may reflect changes in the brain systems
of GABA and glutamate [5].
These findings are important as they indicate altered
cortical excitability in drug-dependent populations and sug-
gest that TMS can be utilized as an investigative tool to
better understand the pathophysiology of addiction. Nev-
ertheless, these studies have several limitations. First, these
were exploratory studies with small samples. Second, it is
difficult to determine whether alterations in the corticospinal
measures are a direct result of chronic drug administration
or, rather, occur due to preexisting vulnerabilities or perhaps
Behavioural Neurology 3
even a combination of both. Finally, poly-substance use
and/or a comorbid psychiatric condition could also exacer-
bate these alterations in cortical excitability.
4. rTMS as a Therapeutic Tool
Repetitive TMS can modulate the excitability of stimulated
cortex and interconnected brain regions, even after the
period of stimulation [11, 12, 29]. It has been reported that
high frequency rTMS (>5Hz) transiently increases cortical
excitability [30, 31]. Changes in neurotransmission induced
by rTMS have been observed in both animal [32, 33] and
human studies [34, 35]. rTMS over the PFC seems to have
modulator effect on mesolimbic and mesostriatal dopamin-
ergic systems. Strafella et al. [34] found that high frequency
rTMS on the prefrontal cortex in humans induces subcortical
release of dopamine in caudate nucleus. Cho and Strafella [35]
showed that rTMS over the left DLPFCmodulates the release
of dopamine in anterior cingulated cortex and orbitofrontal
cortex in the same hemisphere.
The effect of rTMS on dopaminergic neurotransmission
and cortical excitability suggests that this technique can be
used in the study and treatment of various neuropsychi-
atric disorders associated with abnormal dopamine activity
and altered cortical excitability, such as depression [36–39],
obsessive-compulsive disorder [40, 41], schizophrenia [42–
45], and drug addiction [46–56]. The efficacy of adminis-
tering TMS protocols, to frontal brain areas, as a potential
nonpharmacological candidate for increasing dopamine lev-
els in the mesocorticolimbic circuitry and altering neuroad-
aptations induced by chronic drug use has been assessed with
animal studies [5].
5. rTMS in the Treatment of Addiction:
The Rationale and Experimental Evidence
Recent studies have begun to assess the effects of rTMS on
addictive behaviours in humans. Repeated exposure to drugs
can cause long-term neural adaptations in some systems.
These neuroadaptations are partly associated with altered
dopamine activity in the mesocorticolimbic circuitry [57, 58]
and lead to an alteration of glutamate neurotransmission
[59] and cortical excitability [60, 61], which have been
implicated in the persistence of drug-seeking behaviours,
increased difficulties regulating drug-seeking behavior, and
a heightened likelihood of relapse [62].
Because rTMS can affect cortical excitability and increase
the release of dopamine in the mesolimbic dopaminergic
system, it is thought that repeated applications of rTMS
may affect neuroadaptation induced by the chronic use of
substances. In addition, rTMS canmodulate neuronal activity
and, thus, at least induce acute effects on circuitries thatmedi-
ate different behaviours. Repeated sessions of rTMS of the
PFC are, therefore, suggested to reduce drug craving, drug-
seeking, and eventually drug consumption and relapse [48].
There is accumulating evidence that stimulating the dor-
solateral part of the prefrontal cortex (DLPFC) may be of use
in addiction treatment. DLPFC is involved in the decision-
making processes [63] and these processes can be altered by
rTMS [64]. Addiction is associated with increased impulsiv-
ity and willingness to take risks, which in turn can lead to
impaired decision-making [65]. rTMS on the DLPFC could
modulate these decision-making processes in addiction and
thereby reduce impulsivity and enhance inhibitory control,
which may lead to a reduction in the use of substances.
Therefore, the neuropsychological assumption underlying
research using rTMS in the treatment of addiction is that
exciting the DLPFC by high frequency pulses should increase
its activity and increase its inhibitory control function. In
particular, with drug-addicted subjects, this treatment should
increase DLPFC function to cope with drug craving. In fact,
to date, several human studies have evaluated the effects
of rTMS protocols on drug craving, a major component
determining relapse, and consumption in nicotine [46–50],
alcohol- [51–54], and cocaine-dependent groups [55, 56].
The following section describes studies which have
explored the therapeutic potential of rTMS in reducing addic-
tive behaviours within substance-dependent populations.
5.1. rTMS and Nicotine. Five papers which examined rTMS
and nicotine dependence are summarized below and in
Table 1.
Johann et al. [46] and Eichhammer et al. [47] investigated
with exploratory studies whether high frequency rTMS of
DLPFC could decrease nicotine-seeking related behaviours.
In the first pilot double-blind crossover study, Johann et
al. [46] investigated whether rTMS of the DLPFC could
modulate levels of tobacco craving. Eleven treatment-seeking
smokers under 12-hour abstinent conditions were adminis-
tered either one active or one sham session of 20Hz rTMS
over the left DLPFC at 90% of MT. The session consisted of
20 trains of stimuli of 2.5 s.The levels of tobacco craving were
assessed using a 100-point visual analogue scale (VAS) both
30minutes prior to and following the rTMS treatment. rTMS
significantly reduced the level of tobacco craving reported
30 minutes following the treatment [46]. These findings,
therefore, motivated further investigation on the efficacy of
rTMS as a potential treatment in nicotine dependence to
reduce not only the level of craving but also of smoking
consumption.
Following this pilot study, the same research group [47]
investigated the effects of two sessions of active and sham
rTMS at the same parameters with a double-blind crossover
design study. Participants consisted of 14 treatment-seeking
tobacco dependents. All participants were required to
abstain from smoking 12 hours before the rTMS sessions. In
a randomized order, each participant received 2 active trials
and 2 sham stimulation sessions over 4 consecutive days.
Smoking craving was measured at baseline and 30min after
the rTMS session using a VAS. In addition, the number of
cigarettes freely smoked in a 6-hour time period following
treatment was recorded. During this 6-hour time period,
the number of cigarettes smoked following high frequency
rTMS applied to the left DLPFC was significantly decreased,
but craving levels remained unchanged. The authors have
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Table 1: Summary of the studies on rTMS in the treatment of nicotine addiction.
Study
𝑁
subjects
(active,
sham)
Place of
stimulation
Number of
sessions Length Frequency
Intensity of
stimulation
Sham
stimulation Assessment Findings
Johann et al.
(2003) [46] 11
Left
DLPFC 1 session
20 trains of
2.5 s 20Hz 90% MT Yes
Craving, assessed
by VAS
Reduction in
craving
Eichhammer
et al. (2003)
[47]
14 LeftDLPFC
4 sessions
(2 active
and 2
sham)
20 trains of
2.5 s 20Hz 90% MT
Yes
(between
the group)
Craving, assessed
by VAS; cigarettes
number
Reduction in
consumption
Amiaz et al.
(2009) [48] 22, 26
Left
DLPFC 10 sessions
20 trains of
5 s 10Hz 100% MT Yes
Craving, assessed
VAS; cigarettes
number
Reduction in
craving,
consumption,
and
dependence
Wing et al.
(2012)
[49, 66]
6, 9 BilateralDLPFC 20 sessions 50 trains 20Hz 90% MT Yes
Craving, assessed
by TQSU
Reduction in
craving
Rose et al.
(2011) [50] 15 SFG
3 sessions
(1 active
1Hz, 1
active
10Hz,
1MOC)
2.5min
each session
(total
period of
stimulation:
7.5min)
1Hz or
10Hz 90% MT Yes
Craving, assessed
by
Shiffman-Jarvik
questionnaire and
cigarette
evaluation
questionnaire
Reduction in
craving
(10Hz)
DLPFC: dorsolateral prefrontal cortex; SFG: superior frontal gyrus; MOC: motor cortex; MT: motor threshold; VAS: visual analogue scale; TQSU: Tiffany
Questionnaire for Smoking Urges.
suggested that the evaluation of craving may have not been
sensitive enough and that the sample size was probably too
small to detect alterations in craving [47]. Treatment with
high-frequency rTMS was, therefore, found to decrease crav-
ing level for tobacco in the pilot study, although this finding
was not replicated in the second study. The second study
demonstrated reduced smoking consumption following
rTMS session, thus contributing to the preliminary evidence
of the utility of rTMS treatment in nicotine dependence
[67]. Based on these findings, the authors proposed that high
frequency rTMS could have potential therapeutic value in
the treatment of nicotine dependence through a reduction
in the levels of craving [46] and its consumption [47].
Amiaz et al. [48] were also interested in evaluating the
effects of high frequency rTMS of the left DLPFC, combined
with either smoking or neutral cues, on cigarette consump-
tion, dependence, and craving. The researchers expanded
on the previous two studies by assessing whether exposure
to smoking cues (prior to the stimulation) could modulate
the effect of rTMS. They postulated that in addition to
the effect of rTMS on dopamine transmission and cortical
excitability, rTMS over the PFC may disrupt craving-related
circuitries and that this effect would be prominent when
rTMS is applied immediately after activation of such circuitry
by smoking cues. Forty-eight heavy smokers motivated to
quit smoking were recruited for the study. Participants were
randomly divided into real and sham stimulation groups.
Each group was subdivided randomly into two subgroups
presented with either smoking-related or neutral cues just
before the daily TMS intervention. Thus, there were four
experimental groups: active TMS with smoking pictures,
active TMS with neutral pictures, sham TMS with smoking
pictures, and sham TMS with neutral pictures. The authors
assessed the effects of 10 days of treatment with either active
or sham 10Hz rTMS treatment applied to the left DLPFC.
Daily rTMS sessions were applied every weekday and then a
maintenance phase was conducted in which rTMS sessions
were less frequent. Ten daily sessions of high frequency
(10Hz) rTMS over the left DLPFC were administered in an
attempt to induce long-lasting effects. Stimulation included
20 trains/day at 100% of MT and each train consisted of
50 pulses at 10Hz with an inter-train interval of 15 s. Prior
to the rTMS, participants were exposed to either smoking
or neutral visual cues. Cigarette consumption was evaluated
objectively by measuring cotinine (a metabolite of nicotine)
urine levels before the first and the 10th treatment, and
participants were administered standard questionnaires on
nicotine consumption, craving, and dependence. VAS was
used to evaluate levels of nicotine craving before and after
the presentation of the smoking or the neutral cues and after
rTMS administration. rTMS, independent of exposure to
smoking pictures, reduced subjective and objective measures
of cigarette consumption and nicotine dependence. It also
reduced cue-induced craving and blocked the development
of general craving induced by repeated presentation of
smoking-related pictures. However, these effects tended to
dissipate after the 10 daily sessions and the reduction in
cigarette consumption was not significant 6 months after
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treatment termination. Interestingly, there was a trend for
lower cigarette consumption in the active rTMS-smoking
picture group at 6 month followup. Overall, results from
this study suggested that high frequency rTMS over the
DLPFC reduced cigarette consumption and nicotine depend-
ence [48].
Wing et al. [49] examined the efficacy of high frequency
rTMS for smoking cessation in treatment-seeking individuals
with schizophrenia, a population of smokerswho are typically
highly nicotine dependent. These authors completed a 10-
week, randomized, double-blind, and sham-controlled trial
of rTMS (20 sessions; 5 treatments/week in weeks 1–4) as an
adjunct to weekly group therapy and transdermal nicotine
(TN; 21mg) provided in weeks 3–9 in 15 heavily-dependent
smokers aged 18 to 60 with schizophrenia or schizoaffective
disorder. They were motivated to quit within the next month
and the target quit date was the start of week 3. Subjects
were randomly assigned to receive active (𝑁 = 6) or sham
(𝑁 = 9) rTMS. Bilateral rTMS (randomized and counterbal-
anced) was administered to the DLPFC. 20Hz stimulation
was administered at 90% of the resting motor threshold
for 25 trains (30 pulses/train; 30 s intertrain interval; 750
pulses/hemisphere). Sham stimulation was administered in
the single-wing tilt position. Smoking (self-report and breath
carbon monoxide [CO] levels), psychiatric measures (Pos-
itive and Negative Syndrome Scale [PANSS]), and adverse
events were assessedweekly. Craving, using the TiffanyQues-
tionnaire for Smoking Urges (TQSU), and withdrawal, using
theMinnesota NicotineWithdrawal Scale, were assessed pre-
and post-rTMS once during each treatment week.
Consistent with findings in nonpsychiatric smokers [46],
pre- and post-rTMS data collected in week 1 showed that
treatment with rTMS significantly reduced craving. While
there was a robust increase in craving following the rTMS
session in the sham group (due to abstinence from smoking),
posttreatment cravings in the active group were the same or
lower than the pretreatment assessment. rTMS did not alter
craving in weeks 2–4. As short-term smoking abstinence did
not increase craving in these weeks, data obtained in week
1 likely provides the most sensitive measurement of rTMS
effects on craving. Despite attenuation of tobacco craving,
rTMSdid not increase abstinence rates. An increased number
of rTMS sessions may be needed for the effects on craving to
translate to effects on smoking [49].
Rose et al. [50], instead, investigated the rTMS effects
over superior frontal gyrus (SFG), a specific prefrontal
cortex region, which supports cue-induced craving. They
implemented a within-subject design to examine subjective
responses to smoking versus neutral cues and to con-
trolled presentations of cigarette smoke. Fifteen smokerswere
recruited for study participation and were exposed to three
conditions on different days: (1) high frequency rTMS (10Hz)
over superior frontal gyrus (SFG), a specific prefrontal
cortex region, which supports cue-induced craving; (2) low
frequency (1Hz) rTMS over the SFG; (3) low frequency
(1Hz) rTMS over the motor cortex (control condition). In
each condition, subjects were stimulated for three periods
of 2 minutes and 30 seconds at 90% MT. The researchers
evaluated craving for cigarettes and they found that compared
to 1Hz rTMS to the SFG or motor cortex, 10Hz to the
SFG resulted in increased cue-induced craving but lower
craving during presentation of neutral cues. Craving after
smoking cue presentations was elevated in the 10Hz SFG
condition, whereas craving after neutral cue presentations
was reduced. Ratings of immediate craving reduction as well
as the intensity of interoceptive airway sensations were also
attenuated upon smoking in the 10Hz SFG condition. These
findings support the idea that SFG plays a role in modulating
craving reactivity, and that the SFG plays a role in both
excitatory and inhibitory influences on craving but do not
provide evidence for the utility of rTMS of the SFG for the
treatment of tobacco addiction [50].
In summary, as shown in Table 1, the first four stud-
ies described above showed that high frequency rTMS of
the DLPFC can attenuate nicotine consumption [47, 48]
and craving [46, 49]. Rose et al. [50], instead, highlighted
the excitatory and inhibitory influence of SFG on tobacco
cravings but did not provide evidence for the utility of
rTMS of the SFG for the treatment of tobacco addiction.
However, the significance and duration of these effects are
limited and further investigation is required to identify the
appropriate stimulation parameters and targets. While other
types of brain stimulation techniques (transcranial direct cur-
rent stimulation, cranial electrostimulation, and deep brain
stimulation) have been evaluated in the treatment of nicotine
addiction, there is more evidence to support rTMS’s potential
to treat nicotine dependence [66]. According to the criteria
suggested by Brainin et al. (2004) [6], the extant research
on the therapeutic use of rTMS for nicotine dependence
has one study in class II [48], three studies in class III
[46, 47, 50], and one study in class IV [49] that showed
reduction in craving, consumption, and dependence. Thus,
according to the available evidence, rTMS falls within the
level B recommendation as probably effective in the treatment
of nicotine addiction.
5.2. rTMS and Alcohol. Studies of rTMS in alcohol-depend-
ent individuals are summarized below and in Table 2.
Mishra et al. [51] published the first study about rTMS
treatment of alcohol dependence. These authors studied
the anticraving efficacy of high frequency rTMS of the
right DLPFC in a single-blind, sham-controlled study that
involved 45 patients with alcohol dependence. Participants
were assigned to one of the two groups in which they received
either real (𝑁 = 30) or sham (𝑁 = 15) rTMS. They
were administered 10 daily sessions of high frequency (10Hz)
rTMS at 110% of MT over the right DLPFC. Each session
consisted of 20 trains with 4.9 s per train and 30 s inter-
train interval. The Alcohol Craving Questionnaire (ACQ-
NOW) was administered in order to evaluate the extent of
alcohol craving at baseline, immediately after the last rTMS
and a month after the last session. There was a significant
reduction in the post-rTMS ACQ-NOW total score and
factor scores in the group allocated to active rTMS compared
to the group allocated to sham stimulation. It was found that
10 daily sessions of high-frequency rTMS over right DLPFC
had significant anticraving effects in alcohol dependence.
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Table 2: Summary of the studies on rTMS in the treatment of alcohol addiction.
Study
𝑁
subjects
(active,
sham)
Alcohol use
status
Place of
stimulation
Number
of
sessions
Length Frequency Intensity ofstimulation
Sham
stimulation Assessment Findings
Mishra et
al. (2010)
[51]
30, 15 Afterdetoxification
Right
DLPFC
10 daily
sessions
20
trains
of 4.9 s
10Hz 110% MT Yes
Craving,
assessed by
ACQ-NOW
Reduction in
immediate
craving; no
effect on craving
after 4 weeks
Ho¨ppner
et al. (2011)
[53]
10, 9
(females)
14 days after
detoxification
Left
DLPFC
10 daily
sessions
1000
pulses 20Hz 90%MT Yes
Craving,
assessed by
OCDS;
depressive
symptoms,
assessed by BDI;
AB for neutral
and alcohol
related pictures
No reduction in
craving and no
effect on mood;
increase AB for
alcohol related
pictures
Herremans
et al.
(2012) [52]
36 Afterdetoxification
Right
DLPFC
1
session
40
trains
of 1.9 s
20Hz 110% MT Yes
Craving,
assessed by
OCDS
No effect on
immediate and
long-term
craving
de Ridder
et al. (2011)
[54]
1
(female)
Active
drinking
period
dACC
daily
sessions
during
5 weeks
600
pulses 1Hz
50%
machine
output
No Craving,assessed by VAS
Reduction in
immediate
craving and
consumption;
relapse after 3
months with
increased
craving after 3
months
DLPFC: dorsolateral prefrontal cortex; dACC: Dorsal anterior cingulated cortex; MT: motor threshold; VAS: visual analogue scale; ACQ-NOW: Alcohol
Craving Questionnaire; OCDS: obsessive compulsive drinking scale; BDI: Beck Depression Inventory; AB: attentional blink.
This study supports the therapeutic potential of rTMS which,
especially when combined with anticraving drugs, could
represent an effective strategy in reducing craving and alcohol
relapse among alcohol-dependent subjects [51].
Ho¨ppner et al. (2011) investigated the effect of high
frequency rTMS of the left DLPFC compared to sham
stimulation on craving and mood in alcohol-dependent
women. Moreover, this study examined the impact on an
attentional blink (AB) paradigm to pictures with neutral,
emotional, and alcohol-related contents. Nineteen female
detoxified participants were randomized either to a high
frequency rTMS (20Hz) over the left DLPFC (𝑁 = 10) or
sham stimulations (𝑁 = 9) for 10 days. Alcohol craving
was assessed with the Obsessive Compulsive Drinking Scale
and depressive symptoms were assessed by the Hamilton
Depression Rating Scale and the Beck Depression Inventory.
An age-matched control group was investigated for the AB
paradigm. There were no significant differences in clinical
parameters such as alcohol craving or mood after real rTMS
compared to sham stimulation. In the AB paradigm, real
stimulated participants detected alcohol-related T2 targets
incorrectly in comparison to the sham stimulated and control
subjects. Although there were no differences in craving and
mood after real high frequency rTMS compared to sham
stimulation, an interesting difference between the real and
the sham stimulated group and controls was found in the AB
paradigm, suggesting an increase of the AB effect to alcohol-
related pictures after real stimulation [53].
Herremans et al. (2012) performed a prospective, single-
blind, and sham-controlled study in order to investigate the
effect of single high frequency rTMS session of the right
DLPFC on alcohol craving in the community. Participants
(𝑁 = 36) were hospitalized alcohol-dependent patients.
After successful detoxification, participants were allocated
to receive one active or one sham rTMS session. The rTMS
session was administered on friday before the weekend at
home.The rTMS session consisted of 40 trains of 1.9 s at 20Hz
at 110% of MT with a 12 s inter-train interval. The obsessive-
compulsive drinking scale (OCDS) was administered to
assess the intensity of alcohol craving just before and after
the rTMS session (on friday), on saturday and sunday during
the weekend at home, and onmonday (when the participants
returned to the hospital). One high frequency rTMS session
delivered to the right DLPFC did not lead to changes in
craving (neither immediately after the stimulation sessionnor
in participants’ natural environment during the weekend).
This study found that application of a single rTMS session had
no significant effect on alcohol craving [52].
Behavioural Neurology 7
In a case report [54], a 48-year-old woman with a 23-year
heavy drinking history was stimulated with low-frequency
rTMS targeting the dorsal anterior cingulated cortex (dACC)
using a double cone coil in an attempt to suppress very
severe alcohol craving; 1 Hz rTMS (50% of the machine’s
intensity, total of 600 pulses) was delivered for 3 weeks to the
medial frontal cortex. It was a combined rTMS neuroimaging
study: functional magnetic resonance imaging (fMRI) and
resting state electroencephalography (EEG) were performed
before rTMS treatments, after successful rTMS and after
unsuccessful rTMS with relapse. Blood alcohol volumes
were acquired on random days during the treatment course.
Alcohol cravings were measured daily by a VAS during a cue
exposure. Repetitive rTMS reduced alcohol consumption for
the duration of the treatment. Symptoms of withdrawal and
cravings were also reduced up to 3 months. This reduction
was also reflected with the change in fMRI and EEG activity.
After 3 months, the patient relapsed and was treated with
1 week of rTMS. These effects lasted for 3 weeks until the
patient relapsed again and the patient became unresponsive
to the rTMS treatment [54].
In conclusion, 10 daily sessions of high-frequency rTMS
over right DLPFC had significant anticraving effects in
alcohol dependence [51], while a single rTMS session had no
significant effect on immediate and long-term craving; there
were no reduction in craving after high frequency rTMS over
left DLPFC [53]; repetitive rTMS targeting the dACC using
a double cone coil reduced immediate alcohol craving and
consumption [54]. These studies together suggest that rTMS
may play a therapeutic role in alcohol dependence, though
the evidence is still preliminary [68], and also indicate that
one single session could be too short to alter alcohol craving
in alcohol-dependent patients. As we can see in Table 2,
stimulation parameters, such as frequency, % of MT, train
duration, intertrain interval, and area of stimulation, differ
significantly among studies. Based on these findings, Herre-
mans and Baeken (2012) suggested the evaluation of multiple
rTMS sessions in larger, randomized, and sham-controlled
population samples. Furthermore, randomized controlled
studies should be done to evaluate whether patients need
stimulation with high or low frequency [69].
According to the criteria suggested by Brainin et al.
[6], rTMS therapy for alcohol dependence includes one
case report [54] (class IV) and three controlled clinical
trials (class III) [51–53], two of which reported no effect on
craving and one showed reduction in craving. Thus, there is
inadequate evidence to confer a level of recommendation for
its effectiveness.
5.3. rTMS andCocaine. Camprodon and colleagues [55] con-
ducted a preliminary study to examine rTMS as a potential
treatment for the craving experienced by cocaine-dependent
individuals. They investigated whether a single session of
rTMS over DLPFC could reduce cocaine craving among
six male participants with cocaine dependence. Secondary
endpoints were changes in anxiety, happiness, sadness, and
discomfort. In this randomized crossover design, participants
were administered two sessions of high frequency (10Hz)
rTMS at 90% of MT, to the right and left DLPFC, with a
week break between the two sessions. Patients were asked to
complete a set of 15 visual analogue scales (VAS) ranging from
“not at all” to “more than ever.” Each VAS evaluated one of
the primary or secondary endpoints on three occasions: 10
minutes before the intervention and immediately after and 4
hours after rTMS session.
The authors found that a single session of high frequency
rTMS to the right DLPFC, but not to the left DLPFC,
decreased level of craving for cocaine.This is a transient effect
that resolves within 4 h after stimulation.
The resulted anxiety significantly reduced after right-
sided stimulation. Happiness was increased after right-sided
and sadness after left-sided stimulation. Discomfort was
increased equally by left- and right-sided rTMS and the
interaction term was not significant, providing a useful
control for the nonspecific effects of the stimulation.
This research provided the first demonstration that high
frequency rTMS applied over the right DLPFC is effective in
reducing craving associated with chronic use of cocaine [55].
Also Politi et al. (2008) studied the effects of rTMS over the
DLPFC on cocaine cravings among 36 cocaine-dependent
participants studied after detoxification. Ten daily sessions
of high frequency (15Hz) rTMS over the left DLPFC at 100%
of MT were administered. The participants underwent daily
clinical assessment of symptoms associated with cocaine
craving. These authors found that the daily sessions of high
frequency rTMS of the left DLPFC reduced cocaine craving.
Cocaine cravings reduced gradually throughout the sessions
[56].
As shown in Table 3, both these studies [55, 56], using
different paradigms and assessment tools, suggest that rTMS
over the DLPFC can potentially provide an effective thera-
peutic intervention for cocaine craving and addiction. There
was a discrepancy in the laterality of the findings. Further
research is required on the optimal stimulation patterns
and on the exact brain region to stimulate. Future studies
that assess cocaine intake after treatment are also required.
According to the criteria suggested by Brainin et al. [6],
studies of rTMS therapy for cocaine dependence includes
one clinical trial (class III) [55] and one study rated in class
IV [56] that showed reductions in craving. Thus, there is
inadequate evidence to confer a level of recommendation for
the effectiveness of this treatment.
6. Conclusion and Future Studies
In summary, in the research that evaluated the therapeutic
use of rTMS in addiction we have one clinical trial classified
in class II [48] that showed reduction in craving, consump-
tion, and dependence, five trials classified in class III that
support the effectiveness of rTMS [46, 47, 50, 51, 55], and two
studies in the same class that reported the ineffectiveness of
this treatment [52, 53].Thus, based on the available evidence,
rTMS can be classified as probably effective in the treatment
of addiction. At the moment, the best level of evidence
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Table 3: Summary of the studies on rTMS in the treatment of cocaine addiction.
Study 𝑁subjects
Place of
stimulation
Number
of
sessions
Length Frequency Intensity ofstimulation
Sham
stimulation Assessment Findings
Camprodon
et al. (2007)
[55]
6 BilateralDLPFC
2
sessions
20
trains
of 10 s
10Hz 90%MT No
Craving, anxiety,
happiness, sadness,
and discomfort,
assessed by VAS
Reduction in craving (with
right DLPFC rTMS);
reduction in anxiety after
right-sided rTMS; increase
in happiness after
right-sided and in sadness
after left-sided rTMS;
increase in discomfort
equally by left- and
right-sided stimulation
Politi et al.
(2008) [56] 36
Left
DLPFC
10 daily
sessions
20
trains
of 2 s
15Hz 100% MT No
Clinical assessment
of craving related
symptoms
Reduction in craving
DLPFC: dorsolateral prefrontal cortex; MT: motor threshold; VAS: visual analogue scale.
of the effectiveness of rTMS is in the treatment of nicotine
dependence.
The effects of rTMS sessions on drug craving and con-
sumption provide evidence and support for further TMS
studies in the field of addiction research. Most of the studies
that assessed the therapeutic potential of rTMS to treat
alcohol, nicotine, and cocaine addiction were performed
using a figure-of-eight coil targeting DLPFC. These studies
show that high frequency rTMS over the DLPFC can reduce
craving and consumption in nicotine, alcohol, and cocaine-
dependent populations. These studies are still few and have
also methodological limitations: they were exploratory in
nature and consist of relatively small sample sizes. Future
research should identify the optimal parameters (appropriate
target, intensity, frequency, and length) of stimulation in
rTMS studies for the most effective and safe treatment of
drug addiction. Future studieswithmultiple rTMS sessions in
larger, randomized, and sham-controlled population samples
are required.
It is important to note that none of these studies demon-
strated complete abstinence from substance use and few
studies [47, 53] evaluated craving in the natural environment
of the patients. It also could be that subjective craving
assessment is not that reliable [53]. In addition, the period of
rTMS to maintain the gains produced need to be examined
with longer follow-up studies.
Fitzgerald and Daskalakis review reported that high-
frequency rTMS applied to the left DLPFC is an effective
treatment for patients with major depressive disorder [70],
although the review included only two studies [53, 55]
that took in consideration that targeting the DLPFC might
affect mood. Camprodon et al. [55] found that in cocaine
addicted individuals happiness was increased after right-
sided and sadness after left-sided stimulation [55]. These
findings were in contrast with those from studies of patients
with depression, who tend to show the opposite lateralization
[70, 71]. Instead, J. Ho¨ppner et al. (2011) did not find
significant differences in mood after real rTMS over the left
DLPFC in individuals with alcohol dependence [53]. Thus,
more research is needed on the impact of rTMS on mood
in individuals with alcohol and drug dependence. More
studies that measure psychological and neurophysiological
variables, such as frontal activation tasks, quantitative EEG,
evoked potentials, and functional magnetic resonance, along
with rTMS in addiction are required for more comprehen-
sive assessment of the treatment effects. Given the critical
interaction between brain stimulation and cognitive acti-
vation revealed in some studies (e.g., Amiaz et al., 2009),
it is possible that a combination of brain stimulation and
cognitive behavioural therapies would produce a promising
clinical outcome [5].These findingsmight translate across the
spectrum of addictive disorders [72].
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